Highlights Teva Pharmaceutical Industries Limited OTC Markets

Equities

TEVJF

IL0006290147

Market Closed - OTC Markets Other stock markets 11:32:46 25/06/2024 pm IST			5-day change	1st Jan Change
14.7 ^USD	-18.33%		-18.33%	+70.53%

28/06	Teva Pharmaceutical Industries Ltd Announces New AJOVY® (Fremanezumab) Migraine Prevention Data Challenges Treatment Pauses	CI
27/06	Jefferies Adjusts Price Target on Teva Pharmaceutical Industries to $23 From $19, Maintains Buy Rating	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Teva Pharmaceutical Industries Ltd Announces New AJOVY® (Fremanezumab) Migraine Prevention Data Challenges Treatment Pauses	28/06	CI
Global markets live: UBS, Boeing, AT&T, Rivian, Nvidia, Tesla...	25/06
Teva Pharmaceutical Pays $750 Million to Resolve Tax-Related Litigation	25/06	MT
Teva settles tax dispute in Israel with $750 mln payment	25/06	RE
Teva Pharmaceutical Industries Limited Announces Launch of Authorized Generic of Victoza® (Liraglutide Injection 1.8Mg), in the United States	24/06	CI
Global markets live: Tesco, Adobe, Tyson Foods, GameStop, Teva...	14/06
Teva Pharmaceutical Sues Corcept Therapeutics Alleging Market Monopolization for Cushing's Syndrome Drug Korlym	14/06	MT
Teva Pharmaceutical Industries Limited Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24?48 mg/day)	30/05	CI
Teva Pharmaceutical Industries Limited and Alvotech Announce SIMLANDI® Injection Now Available in the U.S	21/05	CI
Sector Update: Health Care Stocks Slipping Wednesday Afternoon	08/05	MT
Teva Pharmaceutical Shares Rise After Reporting Higher Q1 Earnings, Revenue; 2024 Guidance Reaffirmed	08/05	MT
Sector Update: Health Care Stocks Lean Lower Pre-Bell Wednesday	08/05	MT
Sector Update: Health Care	08/05	MT
Teva Pharmaceutical Industries Q1 Non-GAAP Earnings, Revenue Rise; 2024 Guidance Reaffirmed	08/05	MT
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 Revenue $3.82B	08/05	MT
Earnings Flash (TEVA) TEVA PHARMACEUTICAL INDUSTRIES LIMITED Posts Q1 EPS $0.48	08/05	MT
Teva Pharm Q1 profit falls short of estimates, revenue gains	08/05	RE
Teva Pharmaceutical Industries Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05	CI
Teva Pharmaceutical Industries Limited Reaffirms Earnings Guidance for the Full Year 2024	08/05	CI
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	01/05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Teva Pharmaceutical Industries isn't out of the woods yet

February 01, 2024 at 03:11 pm IST

INTERVIEW - Richard Francis, CEO of Teva Pharmaceutical: solid quarter, full-year forecasts raised

August 03, 2023 at 12:49 am IST